NASHVILLE, Tenn. Medical Grand Rounds, presented by the Department of Internal Medicine, resumes May 4 at 12:15 p.m. with "Immune Therapy in Cancer." Phillip E. Lammers, M.D., M.S., MSCI is the featured speaker.
Lammers is Assistant Professor of Hematology and Oncology Medicine at the Department of Internal Medicine. The lecture will be held at the S.S. Kresge Learning Resource Center, Lecture Hall 1.
Objectives
- Describe the pathophysiology of different mechanisms by which the host immune system recognizes and clears tumor cells.
- Discuss the FDA approved immune treatments in various malignancies and the data leading to their approvals.
- Explain the class specific side effects and toxicities of immune therapies.
- Discuss the ongoing and future methods to improve cancer susceptibility to immune therapies.
ACCREDITATION: Meharry Medical College is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
CREDIT DESIGNATION: Meharry Medical College designates this live activity for a maximum 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
About the Meharry-Vanderbilt Alliance
Founded in 1999, the Alliance bridges the institutions of Meharry Medical College and Vanderbilt University. Its mission is to enrich learning and advance clinical research by developing and supporting mutually beneficial partnerships between Meharry Medical College, Vanderbilt University and the communities they serve.
